Clinical trials
Clinical clinical trials
Below are recruiting clinical clinical trials, each written for real people, not researchers. We’re tracking 5,435 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07361237RecruitingPhase 1
HJ-004-02 tablet for EGFR-mutated lung cancer
This early-phase trial tests a once-daily tablet (HJ-004-02) for people with a specific type of lung cancer that has an EGFR mutation. It aims to see if the drug is safe and if it can shrink tumors when other treatments have stopped working.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07360847Recruiting
Understanding recovery from rotator cuff shoulder pain with non-surgical care
This study looks at people with rotator cuff shoulder pain who are starting non-surgical treatments like physical therapy. It aims to understand which factors help people get better, so doctors can provide more personalized care.
LimerickAges 18 years+ - NCT07360600Recruiting
Web-based parent support program with coaching
This study tests a web-based program with brief coaching to help parents of children with disabilities manage stress and emotions. Participation involves using the program and talking with a coach, and you must have internet access and a child who visits a clinic regularly.
Tampa, FloridaAges 18 years+ - NCT07360067Recruiting
Comparing two types of heart pacing for sick sinus syndrome
This study compares two different ways of placing a pacemaker lead to see which one better helps heart function and reduces future heart problems in people with sick sinus syndrome.
Seoul, SeoulAges 19 years+ - NCT07357779Recruiting
Smart insomnia diagnosis and treatment study
This study tests a new smart system that helps doctors diagnose and treat insomnia more effectively. It also looks at how this system affects costs and health outcomes.
Changchun, JilinAges 18 years+ - NCT07356115Recruiting
Pain patterns and pain location in muscle and sports clinics
This study looks at whether people's pain patterns—measured by a simple questionnaire called PainDETECT—are linked to where their pain is and what caused it. It may help doctors better understand and treat different types of pain.
IstanbulAges 18 years+ - NCT07356765Enrolling by invitation
Berberine for negative symptoms of schizophrenia
This trial tests if berberine, a natural supplement, can help reduce negative symptoms like lack of motivation or social withdrawal in people with schizophrenia. It may work by affecting the brain and body.
TianjinAges 18–60 - NCT07358234Enrolling by invitationEarly Phase 1
Comparing two EoE treatments on esophagus widening
This study compares two medicines—Eohilia (an oral steroid) and Dupixent (an injectable biologic)—to see which one better helps widen the esophagus in people with eosinophilic esophagitis (EoE). It may help you if you have active EoE and are looking for a new treatment option.
Scottsdale, ArizonaAges 18 years+ - NCT07361471Recruiting
Ovarian cancer genetics: comparing platinum response groups
This study looks at genetic and other factors that may explain why some people with ovarian cancer respond well to platinum-based chemotherapy for many years, while others do not respond at all. The goal is to better understand these differences to improve future treatments.
Clermont-Ferrand, PUY DE DOMEAges 18 years+ - NCT07358208Enrolling by invitation
Pancreas cancer family registry study
This study is building a registry of people with a strong family history of pancreatic cancer. By joining, you help researchers learn more about who is at risk and how to detect it early.
Rochester, MinnesotaAges 18 years+ - NCT06850480RecruitingPhase 3
Study of JP-1366 tablets for heartburn and acid reflux
This trial tests a new medication, JP-1366, for people with reflux esophagitis (damage to the esophagus from stomach acid). It aims to see if the drug is safe and effective at healing the esophagus and relieving symptoms like heartburn and regurgitation.
Beijing, Beijing MunicipalityAges 18–75 - NCT05041556Recruiting
Study of RTS,S malaria vaccine evidence in local areas
This study checks how well evidence about the RTS,S/AS01 malaria vaccine helps inform health policy. You may be included if you live in a specific local area and your child is the right age for the vaccine schedule, and you agree to participate.
KintampoAges 6 months–4.9 years - NCT06608420Recruiting
Precision Medicine Study for Melanoma
This study looks at using precision medicine to better understand and treat melanoma. Patients with a confirmed melanoma diagnosis can join, helping doctors learn more about the disease and improve care.
Barcelona, CataloniaAges Any age - NCT06170489RecruitingPhase 3
Study of JS004 plus toripalimab for Hodgkin lymphoma
This study tests a new combination of two drugs (JS004 plus toripalimab) versus standard chemotherapy for people with Hodgkin lymphoma that no longer responds to PD-1/PD-L1 immunotherapy. The goal is to see if the new combination works better.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06844136Recruiting
ChemoINTEL test study for ovarian cancer
This study is testing a new lab test (called ChemoINTEL) that looks at how your cancer cells respond to chemotherapy drugs used for ovarian cancer. The goal is to see if the test can predict how well the treatment will work for you.
Liverpool, MerseysideAges 18 years+ - NCT06852287RecruitingPhase 2
Study of chemo, targeted therapy, and immunotherapy for bile duct and gallbladder cancer
This trial tests a combination of chemotherapy directly to the liver, a targeted therapy pill, and an immunotherapy drug for people with advanced bile duct or gallbladder cancer that cannot be surgically removed. The goal is to see if this triple therapy can shrink or control the cancer.
Tianjin, TiaAges 18 years+ - NCT06851299RecruitingPhase 2
Trop2-ADC alone or with immunotherapy for advanced triple-negative breast cancer
This study tests a new drug called Trop2-ADC, either alone or combined with immunotherapy, for people with advanced triple-negative breast cancer. The goal is to see if it can shrink tumors and improve outcomes.
Guangzhou, GuangdongAges 18–70 - NCT06851949RecruitingPhase 2
Vsling device for ventricular repair in heart failure
This trial tests a new device called Vsling, which is placed inside the heart to help reshape the main pumping chamber (left ventricle) in people with heart failure. It may improve your heart's strength and reduce symptoms like shortness of breath.
Be’er Ya‘aqovAges 18 years+ - NCT03919981Recruiting
Testing Cysteamine for cystinosis bone health
This study looks at how cysteamine affects the bone health of people with nephropathic cystinosis, a rare genetic condition. It includes children and adults who are already taking cysteamine by mouth and will follow the study plan closely.
BesançonAges 2 years+ - NCT05868876RecruitingPhase 1
Testing AK127 plus AK104 for advanced cancers
This Phase 1 study tests the safety and early anti-cancer activity of AK127 given together with AK104 in people with advanced solid tumors. You may be considered if standard treatments have already been tried or aren’t suitable for you.
Tianjin, Tianjin MunicipalityAges 18–75 - NCT06453005Recruiting
Comparison of two tooth cap methods for baby molars
This trial compares two ways to fix cavities in baby molars: the SMART Hall technique (a newer, less invasive method) and the traditional stainless steel crown. The goal is to see which works better for children aged 3 to 9.
Tirupati, AndhrapradeshAges 3–9 - NCT06855446Recruiting
Robot games for children with autism
This trial is testing whether playing interactive games with a social robot can help children with autism. The robot is designed to be friendly and engaging, which may help improve social skills.
MilanAges 1.5 years–6 years - NCT05472558RecruitingPhase 1
CAR-NK cell treatment for CD19-positive relapsed lymphoma
This Phase 1 study tests a new immune-cell treatment made from donated cord blood. It aims to treat people whose B-cell lymphoma has come back or did not respond, specifically when the tumor has CD19 on it.
Hanzhou, ZhejiangAges 18–75 - NCT05911932Recruiting
Genetic testing in people with memory or nerve diseases
This study looks at genetic (inherited) information using a blood sample from people who come to a memory/cognitive clinic, including some with related family history. Results may help researchers understand who is at risk and how these conditions develop.
London, OntarioAges 18 years+
Hear when a new Clinical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical?
- Yes. Clin2 currently lists 5,435 recruiting clinical studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.